Leiden University Medical Center

What Leiden University Medical Center does

LUMC is a public university medical center headquartered in Leiden, Netherlands, operating as an integrated academic healthcare, research, and education institution under the Dutch public healthcare and academic system. It serves three primary constituencies: patients requiring specialized and complex medical care (including tertiary/quaternary services in oncology, transplantation, cardiovascular care, rare diseases, and pediatrics through nine specialist centers such as the Heart-Lung Center, Oncology Center, Willem-Alexander Children's Hospital, and Transplantation Center); medical and biomedical students (through three bachelor's programs in Medicine, Biomedical Sciences, and Clinical Technology, and seven master's programs including Population Health Management and Health, Ageing and Society); and clinical and biomedical researchers (through advanced facilities including 7 Tesla MRI, cryo-electron microscopy, BSL-3 containment, Cell and Gene Therapy Center, and Proteomics/Metabolomics Center). Revenue is generated through healthcare service reimbursement under the Dutch Zorgverzekeringswet (Health Insurance Act), government block funding for research and education, and competitive grants (Health~Holland, EU IHI, Eureka), with no private equity, venture capital, or public stock listing involved.

LUMC's core technology and research programs span DNA Pol IIIC inhibitor antibiotic development with Acurx Pharmaceuticals (using cryo-EM at 3.2Å resolution), intraoperative near-infrared fluorescence imaging for pancreatic cancer surgery (CPI-008 with Curadel), electronic genome mapping for repeat expansion disorders (with Nabsys OhmX Platform), longevity genetics research, and population health management analytics via the ELAN data warehouse. Distribution of services occurs through direct hospital services at the Leiden campus, a regional network including Health Campus Den Haag, ELAN primary care network, partnership with Alrijne Ziekenhuis for breast cancer care, and SMART-Triage ambulance telemedicine services. The institution is part of the Leiden Bio Science Park, the largest life sciences and health ecosystem in the Netherlands, and maintains international collaborations including the AZP partnership in Suriname and EU-funded consortia such as PreciseOnco.

Name

Leiden University Medical Center

Legal name

Leids Universitair Medisch Centrum

Website

https://lumc.nl

Company type

Private

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Leiden University Medical Center (LUMC) is a Dutch public university medical center in Leiden providing specialized patient care, biomedical research, and medical education across nine specialist centers and advanced facilities including cryo-EM and 7T MRI.

Ownership category

akta.pro rank

Product category

Academic Medical Center

NAICS

General Medical and Surgical Hospitals (62211)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Academic Medical Centers (AMCs) & Teaching Hospitals (HLAFAAAA)

akta.pro secondary industries

Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Pediatric Specialty Care Centers (e.g., cardiology, oncology, neurology) (HLAFAJAH)

Keywords

• Academic hospital services
• Clinical research programs
• Medical degree programs
• Specialized medical care
• Biomedical research

Headquarters

HQ city

Leiden

HQ country

Netherlands

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Distribution channels4 records

Marketing channels6 records

Core offering

Leiden University Medical Center (LUMC) is an academic medical center that integrates patient care, biomedical and clinical research, and medical education. It operates specialized medical centers for complex and rare conditions, runs bachelor and master degree programs in medicine and health sciences, and conducts biomedical and translational research supported by advanced facilities such as cryo-electron microscopy and 7T MRI.

Product overview

Leiden University Medical Center (LUMC) is a university medical center that operates as an integrated healthcare, research, and education institution rather than a traditional product company. Its offerings comprise specialized clinical care services (including nine specialist centers such as the Heart-Lung Center, Oncology Center, and Willem-Alexander Children's Hospital), academic degree programs (three bachelor's and seven master's programs in medicine and health sciences), and advanced research programs with external collaborations. The ELAN data warehouse enables population health research using pseudonymized regional healthcare data. Research activities include antibiotic development with Acurx Pharmaceuticals (DNA pol IIIC inhibitors including ibezapolstat), cancer clinical trials (FLUOPANC with CPI-008 imaging), genomic research (longevity genetics, electronic genome mapping), and participation in the Eureka-ITEA consortium for AI-enabled literature review. Educational offerings include the MasterMinds Challenge innovation program and the new Sustainable Health and Care minor. The institution operates specialized facilities including cryo-EM, 7T MRI, and BSL-3 containment labs.

Differentiator

Problem solved

Functional benefit

Products and services

• Specialized Medical Centers (Heart-Lung Center, Oncology Center, and other specialty centers)

Quantifiable outcome

• Phase 2 trial showed 54.7% 1-year progression-free survival with PHP plus immunotherapy for metastatic uveal melanoma vs 15.8% with PHP alone
• +2 more outcomes

Segments3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability12 records

Feature3 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• NabsyscoreTechnology or Integration · 15 June 2026Collaboration to develop electronic genome mapping-based assay using Nabsys' OhmX Platform for facioscapulohumeral muscular dystrophy research. LUMC presented data at ESHG 2026 demonstrating platform integration with CRISPR/Cas9 technology for detecting repeat expansion disorders.
• Acurx PharmaceuticalscoreStrategic or Co-development Partner · 11 June 2026Ongoing scientific collaboration focused on DNA pol IIIC inhibitors for antibiotic development. LUMC researchers presented cryo-EM structural data on ibezapolstat at the LED3 Scientific Conference. The partnership includes public-private funding from Health Holland and supports Phase 3 clinical trials for C. difficile infection treatment.
• University of Leiden Medical Center (in Eureka-ITEA consortium)minorStrategic or Co-development Partner · 8 April 2026Participation in Eureka-ITEA research consortium for literature review automation research, collaborating with DistillerSR on AI-enabled evidence extraction from scientific literature.
• ARMR Sciences Inc.minorStrategic or Co-development Partner · 31 March 2026Phase 1 clinical trial of anti-fentanyl vaccine ARMR-100 conducted in Netherlands with LUMC designated as site for Phase 2 challenge testing vaccinated participants' breathing responses with intravenous fentanyl.
• Alrijne ZiekenhuiscoreChannel Partner/ Reseller/ Distributor · 25 March 2026Breast Cancer Center collaboration optimizing care delivery in the joint service area. Partnership includes Health Campus Den Haag collaboration for reflux care research with data network ELAN providing regional healthcare analytics.
• Academisch Ziekenhuis Paramaribo (AZP)coreStrategic or Co-development Partner · 1 March 2026Long-standing medical collaboration including annual pediatric cardiac surgery missions, medical specialist training programs, and curriculum development. AZP is transitioning to university medical center status with LUMC playing a key role in medical specialist education. Two cardiothoracic surgeons currently training at LUMC.
• PhilipsminorStrategic or Co-development Partner · 4 February 2026Part of PreciseOnco research consortium coordinated by Philips, awarded €14.9M EU funding for precision cancer treatment over five years. LUMC participates in clinical studies focused on spectral imaging and AI-guided integrated technologies.
• Curadel PharmacoreStrategic or Co-development Partner · 11 January 2026Phase 2 FLUOPANC trial conducted at LUMC evaluating CPI-008 (cRGD-ZW800-1) imaging agent for margin detection in pancreatic cancer surgery. Both FDA and EMA granted orphan drug designation based on trial data showing strong tumor visualization capabilities.
• Adamis PharmaceuticalsminorStrategic or Co-development Partner · 28 July 2023Clinical study collaboration evaluating the efficacy of ZIMHI (high-dose naloxone) in reversing fentanyl overdoses. The study compared 5mg intramuscular ZIMHI with 4mg intranasal naloxone to inform emergency protocol updates.

Scale indicators3 records

Recent moves1 record

Expansion highlights6 records

Direct peers

• Erasmus MC: University medical center in Rotterdam providing patient care, research, and education across similar specialized centers. Directly comparable as another top-tier Dutch AMC competing for the same research grants, industry partnerships, and tertiary patient referrals.
• Amsterdam UMC: Merger of AMC and VUmc, the largest Dutch AMC by volume. Compares directly to LUMC as a university medical center delivering integrated patient care, research, and education with similar specialized centers and a comparable ecosystem anchor role.
• UMC Utrecht: Dutch university medical center combining patient care, research, and education with a strong focus on regenerative medicine and clinical innovation. Directly comparable to LUMC in scale, structure, and funding model.
• Radboud University Medical Center: Nijmegen-based Dutch AMC focused on patient care, research, and education with similar specialized centers. Comparable to LUMC as a peer AMC competing for the same Dutch national research and tertiary care funding.
• Maastricht UMC+: Dutch academic medical center integrating patient care, research, and education with emphasis on population health and lifestyle medicine. Comparable to LUMC as another public AMC in the Dutch system.
• University Medical Center Groningen (UMCG): Northern Dutch university medical center with comparable scale of clinical, research, and education activities. Comparable to LUMC as a peer AMC competing for talent, grants, and industry partnerships.

Broad incumbents

• Karolinska University Hospital: Large Nordic university hospital affiliated with Karolinska Institutet, combining advanced clinical care with major biomedical research. Comparable to LUMC in scale and AMC structure but broader in geographic reach and reputation.
• Charité – Universitätsmedizin Berlin: One of Europe's largest university hospitals, affiliated with Humboldt and Freie Universität Berlin. Comparable to LUMC as a European AMC integrating clinical care, research, and teaching, but operating at a much larger scale.

Regional players

• University Hospital Zurich (USZ): Swiss university hospital combining tertiary care, research, and teaching. Comparable to LUMC as a regional European AMC with similar structure and academic mission, though operating under a different national healthcare system.

Others

• Philips (research partner / strategic adjacency): Not a peer hospital, but a strategic industry partner coordinating the €14.9M EU-funded PreciseOnco consortium in which LUMC participates. Included as an adjacent ecosystem participant given the deep medtech collaboration model relevant to LUMC's translational strategy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCoMprCOIOatM49UMin68_ZA
• Facebookfacebook.com/LUMC.nl
• LinkedInlinkedin.com/company/lumc
• Instagraminstagram.com/lumcleiden/?hl=en
• Xx.com/lumc_leiden

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Leiden University Medical Center